Emmaus Life Sciences, Inc.
- Dec 14, 2012 · D · $135,846 sold of $135,846 · 3 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
- Sep 7, 2012 · D · $300,000 sold of $2,000,000 · 4 investors · min. $50,000 · role: Executive Officer EDGAR ↗
- Nov 2, 2011 · D · $270,000 sold of $2,000,000 · 2 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
- Oct 26, 2011 · D · $0 sold of $0 · 19 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
- May 9, 2011 · D/A · $2,500,000 sold of $2,500,000 · 12 investors · min. $50,000 · role: Executive Officer EDGAR ↗
- Feb 17, 2011 · D · $450,000 sold of $5,000,000 · 5 investors · min. $50,000 · role: Executive Officer EDGAR ↗
- Oct 18, 2010 · D · $1,611,688 sold of $3,050,000 · 4 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
- Aug 3, 2010 · D/A · $750,000 sold of $1,000,000 · 3 investors · min. $125,000 · role: Executive Officer EDGAR ↗
Raised $4M from 19 investors (100% of the $136K target) as of the latest filing. Michael is listed as executive officer on 8 filings for this deal.
Sources
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.